Skip to content

Out now: the UK pharmaceutical market report, 2026 edition. See the report

BuschPharma

Medicines advertising rules briefing

How UK law and the self-regulatory codes limit the advertising and promotion of medicines, and what that means for marketing and communications.

Format
PDF, approx. 35 pages
Edition
2026 edition
Delivery
Download as soon as your payment arrives
Choose a licence

This is a digital research report. It doesn't promote or supply any medicine, and nothing in it is medical, clinical, legal or investment advice.

What's included

  • The legal framework for advertising medicines in the UK
  • Prescription-only medicines: what may and may not be said, and to whom
  • Regulators and codes, and how complaints are handled
  • Websites, social media and influencer content
  • Worked examples drawn from published rulings

About this pack

Medicines are among the most tightly controlled products in UK advertising. This briefing explains the legal framework, the role of the MHRA and the self-regulatory bodies, and how the rules apply to websites, social media and company communications.

This briefing is general information, not legal advice.

Scope and sources

UK legislation, MHRA guidance and published rulings from the relevant regulators and codes. Not legal advice.

More regulation and compliance

Regulation and compliance

Updated

UK medicines regulation briefing

A plain-English guide to how medicines are authorised, licensed and monitored in the UK, and what has changed since Brexit.

From £199

Regulation and compliance

GDP and GMP compliance guide

What Good Distribution Practice and Good Manufacturing Practice expect of UK companies, and how inspections tend to go.

From £179

Your basket

Your basket is empty.

Browse packs